scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1042770763 |
P356 | DOI | 10.1186/1756-9966-33-16 |
P932 | PMC publication ID | 3926270 |
P698 | PubMed publication ID | 24524692 |
P5875 | ResearchGate publication ID | 260194349 |
P2093 | author name string | Matthias Bros | |
Angelika B Reske-Kunz | |||
Stefanie Trojandt | |||
P2860 | cites work | An interaction network predicted from public data as a discovery tool: application to the Hsp90 molecular chaperone machine | Q21134999 |
I kappa B: a specific inhibitor of the NF-kappa B transcription factor | Q24296774 | ||
A novel PAAD-containing protein that modulates NF-kappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta | Q24300765 | ||
Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation | Q24564127 | ||
Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers | Q27022514 | ||
Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer | Q28264693 | ||
The actin-bundling protein fascin is involved in the formation of dendritic processes in maturing epidermal Langerhans cells | Q28268683 | ||
NF-kappaB and the immune response | Q28271031 | ||
Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways | Q28585900 | ||
Expression of relB is required for the development of thymic medulla and dendritic cells | Q28594949 | ||
Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 | ||
HSP90 at the hub of protein homeostasis: emerging mechanistic insights | Q29616824 | ||
HSP90 and the chaperoning of cancer | Q29617504 | ||
Taking dendritic cells into medicine | Q29619243 | ||
Cancer immunotherapy comes of age | Q29619918 | ||
A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers | Q32133166 | ||
Th1/Th2 balance in cancer, transplantation and pregnancy | Q33833226 | ||
Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells | Q33884442 | ||
Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte | Q33935976 | ||
Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells | Q35239937 | ||
Prostaglandin E2 induces matrix metalloproteinase 9 expression in dendritic cells through two independent signaling pathways leading to activator protein 1 (AP-1) activation | Q35604210 | ||
Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells | Q35910661 | ||
Turning NF-kappaB and IRFs on and off in DC. | Q37183815 | ||
Targeting Hsp90: small-molecule inhibitors and their clinical development | Q37222845 | ||
Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells | Q37286051 | ||
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer | Q37338986 | ||
HSP90 as a platform for the assembly of more effective cancer chemotherapy | Q37973573 | ||
The network interaction of the human cytosolic 90 kDa heat shock protein Hsp90: A target for cancer therapeutics. | Q37975002 | ||
HSP90 inhibition: two-pronged exploitation of cancer dependencies | Q37975881 | ||
The specialized roles of immature and mature dendritic cells in antigen cross-presentation | Q37997315 | ||
Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential | Q39549098 | ||
HSP90 modulates actin dynamics: Inhibition of HSP90 leads to decreased cell motility and impairs invasion | Q39649592 | ||
Blocking NF-κB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death | Q39652497 | ||
Activation of the stress protein response inhibits the STAT1 signalling pathway and iNOS function in alveolar macrophages: role of Hsp90 and Hsp70. | Q39715278 | ||
Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation. | Q40120827 | ||
Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK). | Q40211366 | ||
The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation | Q40425004 | ||
Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide | Q40431320 | ||
The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms | Q42808605 | ||
Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells | Q45101254 | ||
Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC. | Q46079127 | ||
Differential activation of NF-kappa B subunits in dendritic cells in response to Gram-negative bacteria and to lipopolysaccharide. | Q50115551 | ||
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma. | Q51549127 | ||
Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice | Q69842539 | ||
Fascin is involved in the antigen presentation activity of mature dendritic cells | Q73311874 | ||
Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases | Q73520518 | ||
Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors | Q73784782 | ||
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions | Q74179201 | ||
Expression of the actin-bundling protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation | Q74347120 | ||
Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling | Q75424784 | ||
Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference | Q80178345 | ||
Phenotypic and functional effects of heat shock protein 90 inhibition on dendritic cell | Q80427928 | ||
Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy | Q81343360 | ||
Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response | Q82252356 | ||
P304 | page(s) | 16 | |
P577 | publication date | 2014-02-13 | |
P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
P1476 | title | Geldanamycin-mediated inhibition of heat shock protein 90 partially activates dendritic cells, but interferes with their full maturation, accompanied by impaired upregulation of RelB. | |
P478 | volume | 33 |
Q40120736 | Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy |
Q55467257 | BRAF inhibitors stimulate inflammasome activation and interleukin 1 beta production in dendritic cells. |
Q36358976 | HSP90 Inhibitor Geldanamycin as a Radiation Response Modificator in Human Blood Cells |
Q58729712 | Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy |
Search more.